DAFNA Capital Management’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.74M | Buy |
324,775
+10,000
| +3% | +$53.6K | 0.48% | 39 |
|
|
2025
Q1 | $1.68M | Buy |
314,775
+15,000
| +5% | +$80.1K | 0.48% | 42 |
|
|
2024
Q4 | $2.68M | Buy |
299,775
+45,610
| +18% | +$408K | 0.68% | 31 |
|
|
2024
Q3 | $2.8M | Sell |
254,165
-20,000
| -7% | -$220K | 0.66% | 39 |
|
|
2024
Q2 | $2.49M | Buy |
274,165
+50,900
| +23% | +$463K | 0.6% | 38 |
|
|
2024
Q1 | $3.14M | Sell |
223,265
-225,743
| -50% | -$3.18M | 0.72% | 34 |
|
|
2023
Q4 | $3.45M | Buy |
449,008
+153,515
| +52% | +$1.18M | 0.83% | 36 |
|
|
2023
Q3 | $2.2M | Buy |
295,493
+167,840
| +131% | +$1.25M | 0.69% | 37 |
|
|
2023
Q2 | $1.06M | Buy |
127,653
+57,770
| +83% | +$481K | 0.29% | 52 |
|
|
2023
Q1 | $929K | Buy |
+69,883
| New | +$929K | 0.28% | 47 |
|